M. Kurdi

M. Kurdi

Auto-generated profile, based on publicly available information

M. Kurdi

Peoples’ Friendship University of Russia named after Patrice Lumumba

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2026 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
YKY. Kurdi
Y. Kurdi
FKF. Kurdi
F. Kurdi
MKM. Kurdi
M. Kurdi
TPT. N. Pisareva
T. N. Pisareva
ASA. A. Shevalgin
A. A. Shevalgin
ИРИ. В. Решетов
И. В. Решетов
Objective: to present a clinical case of delayed dual-tracer sentinel lymph node biopsy using technetium-99m radiocolloid and indocyanine green fluorescence in a patient who previously underwent nipple-sparing mastectomy with immediate implant-based breast reconstruction, and to analyze the technical feasibility and early perioperative safety of the procedure. Material and Methods. This article presents a clinical case of delayed sentinel lymph node biopsy after previous nipple-sparing mastectomy with immediate implant-based breast reconstruction. The report is descriptive and was not intended to assess diagnostic accuracy, sensitivity, specificity, or the false-negative rate of the technique. A 40-year-old woman with a history of right nipple-sparing mastectomy and immediate implant-based reconstruction underwent delayed axillary sentinel lymph node biopsy for staging regional lymphatic basin. Preoperative lymphatic mapping was performed using periareolar subcutaneous injection of 50 MBq 99m Tc-Nanocoll, followed by lymphoscintigraphy and SPECT-CT. On the day of surgery, indocyanine green was injected intradermally at four periareolar points. intraoperative detection was performed using a near-infrared fluorescence imaging system, MARS, version 2.0.0.7, 2024, and a handheld gamma probe. The primary procedural endpoint was technical success, defined as intraoperative identification and excision of at least one sentinel lymph node. Results. Preoperative lymphoscintigraphy and SPECT-CT demonstrated radiotracer uptake in two right axillary lymph nodes. Intraoperatively, both sentinel lymph nodes were successfully identified and excised using combined gamma-probe detection and fluorescence guidance. Concordance between radioactive and fluorescent signals was observed in both removed nodes. Histological examination showed no metastatic involvement. No intraoperative or early postoperative complications were recorded. The implant, mastectomy flaps and nipple-areolar complex remained viable, with no evidence of ischemia, infection, implant exposure or reconstructive failure. Conclusion. In this clinical case, delayed dual-tracer sentinel lymph node biopsy was technically successful and was not associated with early perioperative complications. These findings indicate the principal technical feasibility of the procedure in this specific clinical situation, but they do not allow assessment of diagnostic accuracy, reproducibility, or oncological safety.

1 July 2026 in medRxiv
Verified
Preprint
Open access
FKF. Kurdi
F. Kurdi
YKY. Kurdi
Y. Kurdi
MKM. Kurdi
M. Kurdi
TPT. N. Pisareva
T. N. Pisareva
NSN. S. Sukortseva
N. S. Sukortseva
IRI. V. Reshetov
I. V. Reshetov
Background: Sentinel lymph node biopsy (SLNB) is an essential component of axillary staging in breast cancer. Fluorescence-guided mapping with indocyanine green (ICG) enables real-time visualization of lymphatic drainage; however, the parameters of fluorescence-signal recording require standardization. Objective: To assess the technical feasibility and clinical applicability of SLNB with ICG under near-infrared (NIR) imaging guidance in patients with breast cancer. Materials and Methods: This prospective single-center study included 30 patients who underwent ICG-guided SLNB between 2023 and 2025. In 24 patients, ICG mapping was combined with technetium-99m radioisotope navigation; in 6 patients, ICG guidance alone was used. The protocol comprised periareolar ICG injection, standardized imaging conditions, and fluorescence-index recording. Results: The protocol was completed in all 30 patients. Fluorescent visualization of the lymphatic pathway and/or the sentinel lymph node (SLN) was achieved in every case, and no ICG-related adverse reactions were recorded. The mean fluorescence index was 213.0 ± 24.7, the median was 206.0 [192.5–237.2], and the min–max was 180–255. Conclusion: SLNB with ICG under NIR imaging guidance demonstrated technical feasibility in a prospective single-center cohort. Quantitative fluorescence-index recording may serve as a component of standardizing intraoperative fluorescence guidance.

28 August 2026 in Russian Journal of Clinical Dermatology and Venereology
Verified
Journal Article
Closed access
NPN.N. Potekayev
N.N. Potekayev
GTG.P. Tereshchenko
G.P. Tereshchenko
AGA.G. Gadzhigoroeva
A.G. Gadzhigoroeva
ASA.L. Savastenko
A.L. Savastenko
MKM. Kurdi
M. Kurdi
OZO.V. Zhukova
O.V. Zhukova
Background. Alopecia areata (AA) and atopic dermatitis (AD) are chronic immune-mediated diseases that frequently coexist in children. Despite established epidemiological links, the internal structure of this comorbidity, including how objective disease severity and polyatopy correlate, remains poorly characterized. Aim. To identify and characterize clinical-immunological phenotypes of AA in children with concomitant AD using cluster analysis. Methods. A single-center, cross-sectional study included 68 children aged 5—16 years with AA and AD. Assessments included disease severity (SALT, SCORAD), age of AA onset, serum total IgE, quality of life (CDLQI), and atopic comorbidity (Atopy Index: 0=AD only, 1=+1 atopic condition, 2=+≥2 conditions). Spearman’s correlation and k-means clustering (variables: SALT, SCORAD, IgE, age of AA onset) were used. Results. Correlation analysis revealed a moderate positive association between AA and AD severity (ρ=+0.512, p<0.001). Earlier AA onset correlated significantly with more severe hair loss (ρ=–0.418, p=0.001). Cluster analysis identified three distinct phenotypes: (1) «Early-Onset, Severe AA» (n=22): Early onset (3.0 years), universal hair loss (SALT 100.0%), high CDLQI (11.0); (2) «Late-Onset, Mild Disease» (n=25): Later onset (8.0 years), mild AA (SALT 18.8%) and AD (SCORAD 22.6), lowest IgE (87.6 IU/mL); (3) «Severe Atopic» (n=21): Extreme atopy with highest IgE (847.0 IU/mL), severe AD (SCORAD 52.7) and AA (SALT 77.5%). A higher Atopy Index was associated with increased AD severity (p=0.003) and IgE levels (p=0.015). Conclusion. This study reveals significant heterogeneity in pediatric AA with AD, delineating distinct phenotypic profiles. The findings suggest at least two pathways to severe alopecia: one driven by very early disease onset and another by a severe, systemic Th2 atopic burden. Stratification by age of onset, disease severity, and atopic load facilitates personalized management and identifies children at the highest risk for severe disease and quality of life impairment.